Catapult Therapeutics

📍 s-Hertogenbosch, Netherlands👥 1 employees
Biotechnology Research🌐 catapult-therapeutics.com
Website LinkedIn
Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is Catapult Therapeutics in?
Catapult Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Catapult Therapeutics based?
Catapult Therapeutics is headquartered in s-Hertogenbosch, Netherlands.